硕世生物：2025年上半年归属于上市公司股东的净利润3992614.61元

Core Viewpoint - The company reported a decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [2] Financial Performance - The company achieved an operating revenue of 175,580,501.65 yuan in the first half of 2025, representing a year-on-year decrease of 1.05% [2] - The net profit attributable to shareholders was 3,992,614.61 yuan, which reflects a significant year-on-year decline of 86.35% [2]